SPOTLIGHT -
October 29th 2024
The president of compliance services discusses the company’s recent expansion into new markets.
August 20th 2024
In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
August 13th 2024
The region is moving to the forefront in integrating therapeutic innovation.
April 11th 2024
Is it possible to win in Asia’s private market?
February 8th 2024
The three key themes likely to shape pharma fortunes in 2024.
Finance Programme for Senior Executives
The Oxford Finance Programme for Senior Executives is for directors from technical backgrounds involved in strategic planning, and delivers the ability to identify which projects to invest in, retain or divest.
Taiwan: Pharma at the Tipping Point
After many years of building up an impressive resource base, the industry is finally ready to take advantage of the wave of enthusiasm and interest surounding pharma and biotech that is sweeping the nation
PharmEssentia: The 30-Year Dream
A small company shows how it can play a major role in a relatively short time frame
Don't Judge a Book by its Cover (Or Its Title)
With a fiercely competitive spirit and grand ambitions that reach far beyond Taiwan, Standard is showing that it is far from the middle-of-the-road company its name implies
The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator
Outgoing EMA Director Thomas Lonngren discusses a decade at the helm of Europe's top regulatory office
China 2020: Walled In No More
Pharma sets the pace for China's ambitious new innovation agenda
Is Euroland Following the US Disclosure Lead?
Cegedim survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spend
FDA Should Improve Rate of Foreign Inspections
November 6, 2010.
Japan: The Real Emerging Market?
With all the money and momentum focused on medicines in emerging markets, it may be time to take a closer look at business opportunities in this more familiar neighbor to the East
Europe Launches Early Drug Development Pilot
A European pilot initiative will test the impact of consultations with a number of stakeholders such as patient representatives and payers on early stage drug development.
EDQM vacancy notice EPD
As part of a team, you will prepare meetings of European Pharmacopoeia groups of experts, contribute to the preparation of working documents for these groups, contribute to the elaboration and revision of European Pharmacopoeia texts and follow up meetings with a view to publication of scientific texts and memoranda.
Euro Soul-Searching on Competition
A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers
Bridging the Digital Skills Gap
The industry is crying out for pharma marketers skilled in the theory and practice of online communication. Training is the key, says June Dawson.
FDA Extends Deadline for Avastin Review
September 21, 2010.
A SWOT Analysis Of The Biosimilars Market
Anjan Selz offers a Strengths, Weaknesses, Opportunities and Threats analysis of the biosimilars market.
Actavis Heads into Biosimilars
September 08, 2010.
Roche Plans Business Makeover
Recipes for Success in India and China
Dr Frank Floether provides a no-nonsense guide to securing a successful alliance in Asia.
EU Generic Applications Down
August 20, 2010.
Finalists for Biotechnica Award Named
13 August, 2010.
EGA Talks Biosimilars
The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.
Choosing Your General Manager for China
With substantial growth predicted in the life sciences industry, appointing the right General Manager (GM) in China has never been more important. But where should he or she come from?
Strategies for Emerging Markets: Seven Keys to the Kingdom
It's back to the future in Pharm Exec's second-annual review of industry prospects in the IMS "Pharmerging 17"
Sanofi Fights FDA Approval of Generic Lovenox
August 2, 2010.
Servier Back in EC's Anticompetitive Behaviour Spotlight
August 01, 2010. French pharma giant accused of providing "misleading" and "incorrect" information.
China: Behind the Screen
To shed some light on China's potential, Pharm Exec sat down with Peter Young, President and Managing Partner of Young & Partners, who recently met with government and industry officials to review the investment and M&A climate for medicines.
Convention Targets Counterfeiting
July 23, 2010.
Europe Earmarks €6bn for Research and Innovation
Drug Safety Experts Call For New Openness
UK Coalition Government Unveils Radical NHS Plans
July 14, 2010.